Ultralife corp (ULBI)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues

106,795

87,190

85,531

-

-

-

-

-

-

-

-

Revenues

-

-

-

82,460

76,427

66,494

78,835

-

-

-

-

Cost of products sold

75,630

61,607

59,299

57,352

53,111

47,144

56,214

-

-

-

-

Revenues

-

-

-

-

-

-

-

101,657

135,737

166,819

154,295

Cost of products sold

-

-

-

-

-

-

-

72,927

101,546

120,163

118,986

Gross profit

31,165

25,583

26,232

25,108

23,316

19,350

22,621

28,730

34,191

46,656

35,309

Operating expenses:
Research and development

6,805

4,508

4,737

5,946

5,603

5,333

5,859

7,216

8,593

8,755

9,451

Selling, general and administrative

16,992

14,520

15,019

15,399

14,233

15,460

17,386

21,628

23,186

26,039

29,407

Intangible Asset Impairment

-

-

-

-

150

0

-

-

-

-

-

Total operating expenses

23,797

19,028

19,756

21,345

19,986

20,793

23,245

28,844

31,779

34,794

38,858

Operating income

7,368

6,555

6,476

3,763

3,330

-1,443

-624

-114

2,412

11,862

-3,549

Other (expense) income:
Interest Income

-

-

-

-

3

13

39

4

5

-

21

Interest and financing expense

539

63

183

263

248

218

238

-

-

-

-

Interest and financing expense

-

-

-

-

-

-

-

440

559

1,138

1,452

Miscellaneous income (expense)

-58

121

2

80

65

-154

-26

-24

171

145

-23

Income before income taxes

6,771

6,613

6,295

3,580

3,150

-1,802

-849

-

-

-

-

Loss from continuing operations before income taxes

-

-

-

-

-

-

-

-574

2,029

10,869

-5,003

Income tax provision - current

-

-

-

-

-

-

-

539

32

-557

31

Income tax provision - deferred

-

-

-

-

-

-

-

15

448

258

171

Income tax provision

1,457

-18,386

-1,369

98

310

268

239

554

-

-299

202

Total income taxes provision

-

-

-

-

-

-

-

-

480

-

-

Net income (loss) from continuing operations

-

-

-

-

-

-2,070

-1,088

-1,128

1,549

11,168

-5,205

(Loss) from discontinued operations, net of tax

-

-

-

-

-

-61

128

-501

-3,687

-17,377

-4,026

Net income

5,314

24,999

7,664

3,482

2,840

-2,131

-960

-1,629

-2,138

-6,209

-9,231

Net income attributable to non-controlling interest

109

69

16

-27

-29

-15

-34

-31

-58

-30

10

Net income attributable to Ultralife Corporation

5,205

24,930

7,648

3,509

2,869

-2,116

-926

-1,598

-2,080

-6,179

-9,241

Other comprehensive (loss) gain:
Foreign currency translation adjustments

255

-1,175

1,469

-2,173

-440

147

6

365

277

-

-

Comprehensive income attributable to Ultralife Corporation

5,460

23,755

9,117

1,336

2,429

-1,969

-920

-1,233

-1,803

-

-

Continuing operations

-

-

-

-

-

-0.12

-0.06

-0.06

0.09

0.65

-0.31

Discontinued operations

-

-

-

-

-

0.00

0.01

-0.03

-0.21

-1.01

-0.23

Net income per share attributable to Ultralife common shareholders – basic (in dollars per share)

0.33

1.57

0.49

0.23

0.18

-0.12

-0.05

-0.09

-0.12

-0.36

-0.54

Net income per share attributable to Ultralife common shareholders – diluted (in dollars per share)

0.32

1.53

0.48

0.23

0.17

-

-

-0.09

-0.12

-0.36

-0.54

Continuing operations

-

-

-

-

-

-0.12

-

-0.06

0.09

0.65

-0.31

Discontinued operations

-

-

-

-

-

0.00

-

-0.03

-0.21

-1.01

-0.23

Weighted average shares outstanding – basic (in shares)

15,783

15,882

15

15,261

16

17,475

17,465

17,403

17,304

17,157

16,989

Weighted average shares outstanding - diluted (in shares)

16,179

16,347

15

15,405

16

17,475

-

17,403

17,336

17,166

16,989